Clearside Biomedical

Home » Clearside Biomedical

Secondary

Clearside Biomedical

We are a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye.

Symbol

CLSD

Last Closing Price
$10.33

Shares
TBD

Anticipated Date
TBD

Underwriters
J.P. Morgan, Cowen

To view the prospectus for Clearside Biomedical, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253